Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of TCF12 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of TCF12 mRNA | affects expression | 17562736
|
D001104 |
Arbutin |
Arbutin results in increased expression of TCF12 mRNA | increases expression | 17103032
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of TCF12 mRNA | decreases expression | 20106945 20064835
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of TCF12 mRNA | decreases expression | 12875902
|
C472511 |
dimethylarsinous acid |
dimethylarsinous acid results in decreased expression of TCF12 mRNA | decreases expression | 16507463
|
D004610 |
Ellagic Acid |
Ellagic Acid results in increased expression of TCF12 mRNA | increases expression | 12002526
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of TCF12 mRNA | affects cotreatment|increases expression | 17183730
|
C027185 |
indirubin |
indirubin results in decreased expression of TCF12 mRNA | decreases expression | 15056799
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of TCF12 mRNA | decreases expression | 18927307
|
D008727 |
Methotrexate |
TCF12 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate results in decreased expression of TCF12 mRNA | decreases expression | 17616710
|
C059514 |
resveratrol |
resveratrol results in increased expression of TCF12 mRNA | increases expression | 12002526
|
D012643 |
Selenium |
Selenium results in decreased expression of TCF12 mRNA | decreases expression | 19244175
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of TCF12 mRNA | affects expression | 19590694
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TCF12 mRNA | decreases expression | 16507463
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of TCF12 mRNA | increases expression | 12016162
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TCF12 mRNA | decreases expression | 15056799
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of TCF12 mRNA | decreases expression | 12875902
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of TCF12 mRNA | affects cotreatment|increases expression | 17183730
|
C047426 |
venlafaxine |
venlafaxine results in decreased expression of TCF12 mRNA | decreases expression | 16341940
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of TCF12 mRNA | decreases expression | 18042343
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
13.81 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
13.81 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
13.81 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.84 | 19490988 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.77 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.96 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.63 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.63 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.54 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.55 | 16183991 16162502 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.87 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.76 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.62 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
8.62 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.99 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.33 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.33 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
4.80 | 17286800 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.80 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.32 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.22 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 15238991 19232924 18316065 18177632 17507914 18396377 18775368 16609825 20603192 18558336 18985861 18940202 17688650 17157402 19460635 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.32 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.03 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.66 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.66 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.83 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.83 | 8888407 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.20 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.92 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.92 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.92 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.92 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.92 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.50 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.73 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.08 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.72 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.72 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
8.72 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.72 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.72 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.51 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
14.07 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
14.07 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
14.07 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
14.07 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.07 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.32 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.41 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.05 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.05 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.54 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.54 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.50 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.68 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.08 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.64 | 12621046 16354765 15340226 8697196 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.64 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
15.54 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
15.54 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
15.54 | 17035595 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.62 | 20423518 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
3.99 | 17287894 17725105 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.99 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.79 | 16303861 17159606 18509181 16391804 18259882 15273666 17454858 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.79 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.69 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
5.36 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.36 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.36 | 9142499 10589399 16925845 17551590 9211117 9664655 9224671 8800419 9125849 14991402 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.36 | 8888407 16575769 17688650 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.25 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.93 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.16 | 19747007 |
MESH:D003866 |
Depressive Disorder |
|
venlafaxine |
4.76 | 20305041 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.04 | 20191521 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.69 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.89 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.73 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.73 | 11834606 19370779 16109766 10663392 17522070 11739529 19420014 16485898 15968718 11287661 19085960 19164858 12958197 12392966 16177239 18071297 10774834 11529661 11421492 12594235 16227642 11743745 17906064 10915739 14986274 16393943 15619225 12705907 16081117 12153990 12540782 19416960 16781746 19923254 2444490 18713872 17562736 14550746 19739265 11461765 14725611 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
11.73 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.73 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
11.73 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.02 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.69 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.96 | 1851702 |
MESH:D004487 |
Edema |
|
resveratrol |
6.59 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.59 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.67 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.67 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
9.11 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.11 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.05 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.94 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.76 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.07 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.84 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.89 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.51 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.21 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.98 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.99 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.61 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.61 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.22 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.81 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.04 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.33 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.33 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.59 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.85 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.22 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.95 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.06 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.12 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.08 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.82 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.82 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.82 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.02 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.81 | 16120746 12621046 15340226 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.09 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.08 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
venlafaxine |
5.45 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.78 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 16354765 8697196 15340226 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.39 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.39 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.92 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.48 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.94 | 16873680 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
indirubin |
5.85 | 11275354 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.87 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.54 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.22 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.56 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.65 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
6.65 | 16467254 |
MESH:D007249 |
Inflammation |
|
resveratrol |
4.92 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.92 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
10.81 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.81 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.68 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.66 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.66 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.79 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.79 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.80 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
2.90 | 16705839 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.02 | 9562676 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.73 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.62 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.83 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.83 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.57 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.57 | 19035177 16891316 17107899 15748426 16140955 16823087 9834237 16331271 17712046 17301526 17339181 19225113 19642359 17294898 17217047 12679006 17506722 16788101 17368321 16935935 19029980 19075265 16766008 17649720 17361223 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.65 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.24 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.65 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.28 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.61 | 19014921 12969438 19460945 19784758 11587558 16611625 16610002 12587719 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.77 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
venlafaxine |
9.77 | 19857765 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
13.89 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
13.89 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.89 | 19073162 19812893 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.89 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.89 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.55 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.55 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.11 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
11.19 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
11.19 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.31 | 20464547 18569708 20135361 18816296 6695378 17053015 20869020 20064080 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.31 | 16712894 15276417 17077188 19931552 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.31 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.89 | 17352296 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.21 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.80 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.16 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.03 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.03 | 15318939 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.75 | 17453147 |
MESH:D008545 |
Melanoma |
|
resveratrol |
5.07 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.07 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.07 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.48 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.34 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
venlafaxine |
4.77 | 16856516 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.76 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.29 | 17112576 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
7.91 | 18765137 18803445 |
MESH:D008881 |
Migraine Disorders |
|
venlafaxine |
7.91 | 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.12 | 16381670 |
MESH:D052016 |
Mucositis |
|
irinotecan |
12.31 | 17159606 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
12.31 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.40 | 16490592 16267019 17164350 17049120 14749477 17935668 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.78 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.94 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.23 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.23 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.99 | 16317513 17015251 17188708 17125593 16525036 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.77 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.77 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.67 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.78 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.14 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.01 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.01 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.01 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.94 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.94 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.22 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.22 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.82 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.82 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.82 | 8888407 16359493 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.43 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.11 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.11 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.64 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.31 | 17929310 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
venlafaxine |
5.58 | 17503984 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.35 | 16049721 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.17 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.79 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.79 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.34 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.34 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.43 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.81 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
22.56 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
22.56 | 11896295 11222880 11118676 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
22.56 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
22.56 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.85 | 18220299 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.69 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.11 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.11 | 12479363 18247401 16644109 15754350 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.11 | 16731767 17675339 17718901 17636462 15767336 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.11 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.85 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.52 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.46 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.40 | 17410198 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.71 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.62 | 17352296 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.50 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.23 | 17058453 16314181 17520802 15827377 16317513 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.58 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.58 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.74 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.74 | 14763951 16876388 3137016 11044598 17978042 1511512 15475178 11738929 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
17.49 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
17.49 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
17.49 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
17.49 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
17.49 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.31 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.31 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.46 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.36 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.36 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.36 | 17261132 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.40 | 16321402 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.95 | 9562676 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
4.86 | 15864552 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.96 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.65 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.65 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.15 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.17 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.44 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.09 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.09 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.09 | 17306315 11723127 16452187 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.56 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.23 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.89 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
15.43 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
15.43 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
15.43 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.05 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.53 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.21 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.97 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.89 | 16287080 |